Eric Eldering Selected Research

Eric Eldering Research Topics

Disease

29	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 08/2008
24	Neoplasms (Cancer) 05/2024 - 07/2004
7	Multiple Myeloma 01/2023 - 09/2010
6	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 06/2011
4	Leukemia 01/2023 - 01/2019
3	Infections 01/2023 - 02/2012
3	Melanoma (Melanoma, Malignant) 01/2023 - 09/2012
3	Inflammation (Inflammations) 10/2013 - 06/2004
2	Starvation 05/2024 - 01/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 01/2022
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2022
2	Lymphoma (Lymphomas) 01/2022 - 03/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2012
2	Lymphadenopathy 01/2016 - 03/2012
2	Lymphocytosis 01/2016 - 03/2012
2	Virus Diseases (Viral Diseases) 09/2012 - 05/2012
2	Human Influenza (Influenza) 02/2012 - 06/2010
2	Rheumatoid Arthritis 03/2010 - 07/2009
1	Hypoxia (Hypoxemia) 02/2024
1	Bites and Stings (Sting) 01/2023
1	B-Cell Leukemia (Leukemia, B Cell) 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Adenocarcinoma 12/2022
1	Disease Progression 06/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	COVID-19 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Reinfection 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 10/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2019

Drug/Important Bio-Agent (IBA)

10	venetoclaxIBA 07/2023 - 08/2015
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2009
8	Phosphotransferases (Kinase)IBA 01/2023 - 07/2013
5	AntigensIBA 01/2023 - 01/2010
5	ChemokinesIBA 12/2022 - 09/2009
5	LigandsIBA 01/2017 - 10/2004
4	CytokinesIBA 01/2023 - 11/2013
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
3	Interleukin-8 (Interleukin 8)IBA 12/2022 - 10/2013
3	ibrutinibIBA 12/2021 - 03/2012
3	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021 - 03/2012
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2009 - 08/2008
2	Death Domain ReceptorsIBA 02/2023 - 12/2022
2	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2023 - 01/2016
2	SerpinsIBA 01/2023 - 05/2003
2	Bispecific AntibodiesIBA 01/2022 - 01/2020
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 06/2021 - 06/2011
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2004
2	AntibodiesIBA 08/2015 - 06/2011
2	Dasatinib (BMS 354825)FDA Link 01/2014 - 12/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2013 - 09/2002
1	Glutamine (L-Glutamine)FDA Link 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	Prostaglandins AIBA 11/2023
1	InterferonsIBA 01/2023
1	Casein Kinase II (Casein Kinase 2)IBA 01/2023
1	Bacterial VaccinesIBA 01/2023
1	serum P-component (CIt)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	ThapsigarginIBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Cyclin D1IBA 01/2022
1	selicrelumabIBA 06/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Syk KinaseIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	navitoclaxIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 12/2020
1	Bendamustine Hydrochloride FDA Link 12/2020
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 01/2020
1	RNA Splicing FactorsIBA 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	idelalisibIBA 10/2019
1	Janus Kinase InhibitorsIBA 10/2019
1	EnzymesIBA 01/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2019
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2019
1	pevonedistatIBA 01/2019
1	Platelet-Derived Growth FactorIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CC ChemokinesIBA 01/2017

Therapy/Procedure

10	Therapeutics 01/2023 - 06/2011
5	Immunotherapy 12/2022 - 09/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2009